Purpose: To prospectively study the effects of loco-regional radiotherapy i
n women with breast cancer.
Methods and Materials: Thirty consecutive patients with breast resection un
derwent clinical, lung function, radiographic, and thoracic high-resolution
computed tomography evaluation before and at 1, 3, 6, and 12 months after
adjuvant radiotherapy. Chemotherapy was also administered to 15 patients.
Results: Nineteen patients reported mild respiratory symptoms at 1 month, w
hich resolved completely at 6 months after radiotherapy, Opacities were pre
sent on 80% of chest radiographs and in all patients on high-resolution com
puted tomography by 3 months. These opacities became compact and persisted
on high-resolution computed tomography at 12 months. Lung function indices,
including FEV1, FVC, TLC, and DLCO, progressively declined after radiother
apy, and was irreversible at 12 months (p < 0.05), Patients who received ch
emotherapy did not have significantly different lung function indices compa
red with their counterparts at all time points (p > 0.05).
Conclusions: Our results have shown that adjuvant loco-regional radiotherap
y, a common practice in breast cancer treatment, is associated with irrever
sible reduction in lung function parameters. These changes are accompanied
by radiological evidence of persistent lung injury. Further studies should
be performed to evaluate the incidence and long-term pulmonary sequelae of
current treatment for breast cancer, (C) 2001 Elsevier Science Inc.